CVB homepage

Thumbnail

The new document, published in both the Journal of the American College of Cardiology and Circulation, highlights the significant progress researchers and clinicians have made in this area in recent years.

Thumbnail

The noninvasive treatment option could potentially improve care for many patients, including those scheduled to undergo TAVR. 

The NIH-funded study was published in Arteriosclerosis, Thrombosis and Vascular Biology.

Thumbnail

Researchers noted that these patients received care in the same hospitals and were treated by the same physicians. So why the difference in outcomes? 

Thumbnail

Researchers found that a simple three-part intervention could help patients feel more at ease about their results. 

Thumbnail

The study’s authors tracked data from more than 13,000 patients with malignant melanoma and more than 25,000 patients with lung cancer.

Innovation at work

The late-breaking five-year results of the Evolut Low-Risk Trial presented at ACC.25 showed positive results for the Evolut TAVR system when compared to SAVR.

Sponsored by Medtronic

Around the web

One of the most formidable societies of medical professionals in the U.S. is going toe-to-toe with Robert F. Kennedy’s HHS over changing vaccination recommendations. 

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.